203 related articles for article (PubMed ID: 6214262)
1. [Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)].
Grimm H
Arzneimittelforschung; 1982; 32(6):595-7. PubMed ID: 6214262
[TBL] [Abstract][Full Text] [Related]
2. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
3. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
Martino P; Venditti M; Valente B; Brandimarte C; Serra P
Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
[TBL] [Abstract][Full Text] [Related]
5. [Combinations of mezlocillin with other antibiotics. A review of in vitro laboratory studies (author's transl)].
Courtieu AL; Billaudel S; Drugeon HB; Chung SS
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):329-31. PubMed ID: 6460970
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
Fass RJ
Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
[TBL] [Abstract][Full Text] [Related]
7. Comparative activities of 13 beta-lactam antibiotics.
Muytjens HL; van der Ros-van de Repe J
Antimicrob Agents Chemother; 1982 Jun; 21(6):925-34. PubMed ID: 7114839
[TBL] [Abstract][Full Text] [Related]
8. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
Le Noc P; Robert J; Le Noc D
Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
[TBL] [Abstract][Full Text] [Related]
9. Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Miller MA; LeFrock JL; Vercler MJ
Microbiol Immunol; 1981; 25(11):1119-27. PubMed ID: 6276701
[TBL] [Abstract][Full Text] [Related]
10. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
Bartmann K; Tarbuc R
Infection; 1982; 10(6):361-70. PubMed ID: 6818153
[TBL] [Abstract][Full Text] [Related]
11. [Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776].
Joly-Guillou ML; Serieys C; Verin-Prevost C; Bergogne-Berezin E
Pathol Biol (Paris); 1983 May; 31(5):392-5. PubMed ID: 6353329
[TBL] [Abstract][Full Text] [Related]
12. [N-Formimidoyl-thienamycin in Animal Studies].
Ritzerfeld W
Arzneimittelforschung; 1983; 33(3):470-2. PubMed ID: 6575782
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.
Livingston WK; Elliott AM; Cobbs CG
Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975
[TBL] [Abstract][Full Text] [Related]
14. N-formimidoyl-thienamycin a novel beta-lactam: an in-vitro comparison with other beta-lactam antibiotics.
Wise R; Andrews JM; Patel N
J Antimicrob Chemother; 1981 May; 7(5):521-9. PubMed ID: 6790507
[No Abstract] [Full Text] [Related]
15. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Corrado ML; Landesman SH; Cherubin CE
Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
[TBL] [Abstract][Full Text] [Related]
16. [Sensitivity to mezlocillin Gram-negative aerobic bacilli according to their pattern of resistance to the usual beta-lactam antibiotics (author's transl)].
Witchitz JL; Faurisson F; Christol D
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):314-7. PubMed ID: 6460966
[TBL] [Abstract][Full Text] [Related]
17. Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.
Michael PR; Alford RH; McGee ZA
Antimicrob Agents Chemother; 1981 Nov; 20(5):702-4. PubMed ID: 6798926
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Braveny I; Machka K; Elsser R
Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
[TBL] [Abstract][Full Text] [Related]
19. [Antibacterial spectrum of mezlocillin and azlocillin, two new antibiotics of the ureidopenicillin group (author's transl)].
Roy C; Segura C; Fuster C; Tirado M; Foz A
Med Clin (Barc); 1982 May; 78(9):363-71. PubMed ID: 6212725
[No Abstract] [Full Text] [Related]
20. [6R-[(R)-2-[3-[2-(p-Aminosulfonyl)anilino-4-hydroxy-5- pyrimidinyl]ureido]-2-(4-hydroxyphenyl)acetamido]-penicillanic acid, sodium salt (VX-VC 43), a new broad-spectrum beta-lactam antibiotic. In vitro and in vivo antibiotic activity].
Lechner U; Appel KR; Werner RG
Arzneimittelforschung; 1985; 35(1A):351-5. PubMed ID: 3838677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
